[go: up one dir, main page]

DK1965775T3 - Oralt præparat med kontrolleret frisætning - Google Patents

Oralt præparat med kontrolleret frisætning

Info

Publication number
DK1965775T3
DK1965775T3 DK06829665.6T DK06829665T DK1965775T3 DK 1965775 T3 DK1965775 T3 DK 1965775T3 DK 06829665 T DK06829665 T DK 06829665T DK 1965775 T3 DK1965775 T3 DK 1965775T3
Authority
DK
Denmark
Prior art keywords
pellet
core
active agent
tablet
less
Prior art date
Application number
DK06829665.6T
Other languages
English (en)
Inventor
Burkhard Schluetermann
Manfred Kohlmeyer
Original Assignee
Add Advanced Drug Delivery Tec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Add Advanced Drug Delivery Tec filed Critical Add Advanced Drug Delivery Tec
Application granted granted Critical
Publication of DK1965775T3 publication Critical patent/DK1965775T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK06829665.6T 2005-12-16 2006-12-15 Oralt præparat med kontrolleret frisætning DK1965775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005060393A DE102005060393A1 (de) 2005-12-16 2005-12-16 Orales Präparat mit kontrollierter Freisetzung
PCT/EP2006/012134 WO2007073894A2 (de) 2005-12-16 2006-12-15 Orales präparat mit kontrollierter freisetzung

Publications (1)

Publication Number Publication Date
DK1965775T3 true DK1965775T3 (da) 2010-10-11

Family

ID=38089421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06829665.6T DK1965775T3 (da) 2005-12-16 2006-12-15 Oralt præparat med kontrolleret frisætning

Country Status (10)

Country Link
US (1) US9005658B2 (da)
EP (1) EP1965775B1 (da)
AT (1) ATE470437T1 (da)
DE (2) DE102005060393A1 (da)
DK (1) DK1965775T3 (da)
ES (1) ES2347355T3 (da)
PL (1) PL1965775T3 (da)
PT (1) PT1965775E (da)
SI (1) SI1965775T1 (da)
WO (1) WO2007073894A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
CN103385862B (zh) * 2012-05-08 2015-09-30 重庆国中医药有限公司 一种酒石酸美托洛尔缓释片及其制备方法
CN104274387A (zh) * 2013-07-03 2015-01-14 广东东阳光药业有限公司 美托洛尔缓释组合物
PL3166599T3 (pl) * 2014-07-09 2025-09-22 Sun Pharmaceutical Industries Ltd Postać dawkowania w formie kapsułek zawierających bursztynian metoprololu
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5328697A (en) 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
EP1355633B1 (en) 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
US7022342B2 (en) * 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
WO2005084636A2 (en) 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol

Also Published As

Publication number Publication date
PT1965775E (pt) 2010-08-18
PL1965775T3 (pl) 2011-02-28
ES2347355T3 (es) 2010-10-28
US9005658B2 (en) 2015-04-14
US20090311319A1 (en) 2009-12-17
EP1965775A2 (de) 2008-09-10
ATE470437T1 (de) 2010-06-15
DE502006007201D1 (de) 2010-07-22
EP1965775B1 (de) 2010-06-09
SI1965775T1 (sl) 2010-10-29
WO2007073894A2 (de) 2007-07-05
DE102005060393A1 (de) 2007-06-21
WO2007073894A3 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
TW200502006A (en) Controlled release preparation
IL192374A0 (en) Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
NZ610701A (en) Once daily formulation of lacosamide
ATE476176T1 (de) Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
UA95993C2 (ru) Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
JP2006522739A5 (da)
WO2011084593A3 (en) Abuse-resistant formulations
NZ596403A (en) Microcapsules with improved shells with wax in the outer shell
WO2008101743A3 (de) Pellets mit magensaftresistenter wirkstoff-matrix
NZ594102A (en) Sustained release of nutrients in vivo
TW200906317A (en) Embedded liquid lubricants for tableting
WO2008008592A3 (en) Multi-particulate formulation having tramadol in immediate and controlled release form
AU2008303230B2 (en) Composition and method of stabilized sensitive ingredient
WO2007041367A3 (en) Oral composition containing a salivation inducing agent
DK1965775T3 (da) Oralt præparat med kontrolleret frisætning
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
SI1677777T1 (sl) Peleti, ki vsebujejo venlafaksin hidroklorid
ATE471664T1 (de) Materialzusammensetzung, die cholinchloridhaltige partikel umfasst, für die verabreichung in pansengeschützter, postruminal wirksamer form
WO2007126732A3 (en) Ruminant feed composition and method of making
ZA200805793B (en) Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
EA200901191A1 (ru) Фармацевтическая композиция, содержащая активный ингредиент аторвастатин
KR20080104910A (ko) 서방성 고형 제제 및 그의 제조방법
WO2007096902A3 (en) Solid oral dosage forms of griseofulvin
UA86787C2 (ru) Таблетка с покрытием, которая содержит венлафаксин или его соли и имеет контролируемое высвобождение
CN106691876A (zh) 碳材料面膜